Skip to main content

Metabolomics and Ethnopharmacology in the Development of Herbal and Traditional Medicine

Cover image for Research Topic "Metabolomics and Ethnopharmacology in the Development of Herbal and Traditional Medicine"
343kviews
Editorial31 March 2022
Editorial: Metabolomics and Ethnopharmacology in the Development of Herbal and Traditional Medicine

*Correspondence: Dr Sayeed Ahmad (E mail: sahmad_jh@yahoo.co.in) Herbal and traditional medicines gaining popularity around the world, with many people turning to these remedies for management of variety of health problems. About 80% of the world's population in the developing world rely on herbal remedies as their major source of healthcare.As the use of ethnomedicinal products grows and more new products are introduced to the market, safety and efficacy become the major concern for the researchers. It is important to understand the composition, safety, effectiveness, drug-drug or drug-food interactions and also possible side effects of traditionally used herbal medicines. The safety and efficacy data for herbal and traditional medicines are insufficient to meet the requirements for their worldwide use.The traditional medicines are derived from local and empirical knowledge often transmitted orally and have been developed over generations. The traditional healers of Indian AYUSH (Ayurveda, Yoga, Unani, Siddha, and homeopathy) and Traditional Chinese Medicine (TCM) mainly emphasize on holistic approaches with a focus on the therapeutic practice and outcomes.Metabolomics and metabolomic profiling of herbal medicines and medicinal plants have provided new avenues of research in drug development by identifying and analyzing their metabolome.Metabolomic approaches allow the possibility of modulating many targets, genes, and diseases.Further, it gives the concept of multicomponent multitarget synergistic effects and polypharmacology, as well as holistic approaches of treatments as per AYUSH, and other traditional systems of medicine. Synergistic effects are over additive effects observed in experimental and clinical studies. Incorporating omics technologies in herbal and traditional medicine will help in rationalizing the biological effects by unfolding the possible mechanism of synergistic actions. Such tools will allow us to explore possibilities of standardization of multicomponent extracts and formulations, dereplication, and prediction of the toxicity and safety using network pharmacology and system biology.Metabolomics is one of the techniques to identify the targeted and untargeted metabolites for scientific validation and development of herbal and traditional medicine, especially with the high throughput extensive identification method. The probability of repetition, or working on numerous samples with the similar active metabolites, is one of the challenges of natural product-based drug development. To overcome these problems, various 'de-replication' methods have been developed.A metabolomic technique combined with a suitable biostatistical method has the ability to facilitate fast analysis of composite data generated by high throughput screening.The scope of this special issue on ethnopharmacology and metabolomics is to focus on quality, safety and efficacy of traditional specially AYUSH and herbal medicines with more emphasis on metabolomic studies using hyphenated techniques. This issue contains four review articles and twenty-nine research articles by different research groups around the globe on the related topics. Fu et al., studied the active constituents and mechanism of action of Fuzheng Huayu formula (FZHY), which is a traditional Chinese medicine used for liver fibrosis. The main active components of FZHY are salvianolic acid B, schisantherin A, and amygdalin, which significantly improves the condition of liver in CCl4-and BDL-induced fibrotic liver in rats and mice. In addition to this, the formulation inhibits the activation of hepatic stellate cells by inactivating notch signaling. The authors conclude that the results are adequate to prove scientific evidence for its clinical research, and can act as a potential candidate for liver fibrosis. Kimura & Migo (Orchidaceae), polysaccharide is used in Chinese medicine for liver protection and hypoglycemic action. Qu et al., studied in vitro and in vivo effects of D. officinale polysaccharide in insulin resistance and abnormal lipid metabolism. The results of the study proved that this traditional medicine may serve as a potential therapeutic agent for obesityrelated insulin resistance and lipid metabolism. Kulyal and group, studied about the variability in secondary metabolites across the five cultivars of Curcuma longa L. and two cultivars of C. aromatica Salisb. The analysis was carried out on rhizomes and essential oils using GC-MS and LC-MS methods. Among many detected compounds by the authors, 28 compounds were common in all seven cultivars and 39 new metabolites were detected from all seven species.

Editorial

METABOLOMICS AND ETHNOPHARMACOLOGY IN THE DEVELOPMENT OF HERBAL AND TRADITIONAL MEDICINE

Sayeed Ahmad1*, Chandra Kant Katiyar2, Gudrun S. Ulrich-Merzenich3, Pulok Kumar Mukherjee3,4,

1Bioactive Natural Product Laboratory, Department of Pharmacognosy and Phytochemistry, School of Pharmaceutical Education and Research, Jamia Hamdard University, India

2Emami (India), Calcutta, India

3University Hospital Bonn, Germany

4School of Natural Product Studies, Jadavpur University, Kolkata, India

5Institute of Bio-Resources and Sustainable Development (IBSD), Imphal, India

*Correspondence: Dr Sayeed Ahmad (E mail: sahmad_jh@yahoo.co.in)

Herbal and traditional medicines are gaining popularity around the world, for the management of a variety of health problems, which has been boosted a lot by COVID 19. As the use of herbal / traditional medicines and other botanical products grows. More and more new products are being introduced to the market and thus new and efficient methods to assess safety and efficacy becomes major concern for researchers in drug development. It is important to understand the composition, safety, effectiveness, drug-drug or drug-food interactions and also possible side effects of traditionally used herbal medicines. The safety and efficacy data for herbal and traditional medicines are presently insufficient to meet the requirements for their worldwide use.

The traditional medicines are derived from local and empirical knowledge often transmitted orally and have been developed over generations. The traditional healers of Indian AYUSH (Ayurveda, Yoga, Naturopathy, Unani, Siddha, Sowa-Rigpa and Homeopathy), Traditional Chinese Medicine (TCM) and other traditional systems of medicine mainly emphasize on holistic approaches with a focus on the therapeutic practice and outcomes.

Metabolomics and metabolomic profiling of herbal medicines and medicinal plants have provided new avenues of research in drug development. Metabolomic approaches allow the simultaneous identification of thousands of metabolites present in medicinal plants or herbal medicines. Further, it supports the mechanistic understanding of the concept of multicomponent multitarget effects and polypharmacology, as well as holistic approaches of treatments as per AYUSH, and other traditional systems of medicine. Synergistic effects are often claim in experimental and clinical studies using multicomponent herbal preparations. Incorporating omics technologies into the assessment of mode of action of herbal and traditional medicine will help in rationalizing the biological effects by unfolding the possible mechanism of synergistic actions. Such tools will allow us to explore possibilities of standardization of multi-component extracts and of formulations, of dereplication, and of the prediction of the toxicity and safety of herbal preparations. Such a system biology approach should include network pharmacology assessments as well.

Metabolomics is one of the techniques to identify the targeted and untargeted metabolites for scientific validation and development of herbal and traditional medicine, especially by using high throughput screening methods. The probability of repetition, or working on numerous samples with similar active metabolites, is one of the challenges of natural product-based drug development. To overcome these challenges, various 'de-replication' methods have been developed. A metabolomic technique combined with a suitable biostatistical method has the ability to facilitate fast analysis of composite data generated by high throughput screening.

The scope of this special issue on ethnopharmacology and metabolomics is to focus on quality, safety and efficacy of traditional specially AYUSH and herbal medicines with more emphasis on metabolomic studies using hyphenated techniques. This issue contains four review articles and twenty-nine research articles by different research groups around the globe on the related topics.

Fu et al., studied the active constituents and mechanism of action of the Fuzheng Huayu formula (FZHY), which is a traditional Chinese medicine used for liver fibrosis. The main active components of FZHY are salvianolic acid B, schisantherin A, and amygdalin, which significantly improves the condition of the liver in CCl4- and BDL-induced fibrotic liver in rats and mice. In addition to this, the formulation inhibits the activation of hepatic stellate cells by inactivating notch signaling. The authors conclude that the results provide promising scientific evidence for further investigations with the ultimate goal to bring the formula into clinical research, as a potential candidate for liver fibrosis.

Dendrobium officinale Kimura & Migo (Orchidaceae), polysaccharide is used in Chinese medicine for liver protection and hypoglycemic action. Qu et al., studied in vitro and in vivo effects of D. officinale polysaccharides in insulin resistance and abnormal lipid metabolism. The results of the study proved that this traditional medicine may serve as a potential therapeutic agent for obesity-related insulin resistance and lipid metabolism.

Kulyal and group, studied the variability in secondary metabolites across the five cultivars of Curcuma longa L. and two cultivars of C. aromatica Salisb. The analysis was carried out on rhizomes and essential oils using GC-MS and LC-MS methods. Among many detected compounds by the authors, 28 compounds were common in all seven cultivars and 39 new metabolites were detected from all seven species.

The work of Yan et al., includes the effect of Huanglong granule (HL Granule) in acute asthma and the possible underlying mechanism of action on mice. Changes in the lipid composition were identified using UHPLC-Q-exactive Orbitrap MS with a focus on pulmonary lipid homeostasis. In positive and negative ion modes, a total of 304 and 167 lipids, respectively were identified in lung tissues, with 162 and 109 lipids, significantly elevated in the model group. Authors observed that the HL Granules reversed 104 and 73 lipids, respectively, with statistical difference (FDR < 0.05). It was concluded that lipid homeostasis plays an important role in asthma and HL Granule might be further investigated and developed as an adjuvant therapy for acute asthma.

The effect of Lysimachia candida Lindl. on fatty liver disease in rats was investigated by Kamboj et al., The majority of the metabolites found in both control and treatment groups, related to lipid metabolism. Treatment with L. candida extract improved lipid metabolism control and reversed the metabolic syndrome phenotype in rats.

Zhao et al., investigated the mechanism of a traditional Chinese medicine, Erchen Decoction. The composition and function of gut microbiota in obesity and its relation with lipid metabolism disorders were investigated. The underlying mechanism of obesity due to changes in the composition of gut microbiota was also studied by the authors. Erchen Decoction reduced body weight, improved insulin resistance and lipid metabolism, and reduced the concentration of free fatty acids released from white adipose tissue due to excessive lipolysis in rats. This study supports the hypothesis that the basis for treatment of obesity lies in changes in gut microbiota.

According to Liu et al., a Traditional Chinese Medicine Ramulus mori (Sangzhi) alkaloid (SZ-A) tablets improved the overall metabolic profile in mice, including glucose metabolism with enhanced insulin response and also improved lipid metabolism, which was collectively linked to the modulation of gut microbiota.

Sharma et al., worked on three different dosage forms of Guduchi stem, i.e. Tinospora cardifolia (Willd.) Miers by adopting the Ayurvedic pharmaceutical process of Bhavana (levigation). The findings of this study indicated the effectiveness of SBGC (Svarasa Bhavita Guduchi Churna) and KBGC (Kwatha Bhavita Guduchi Churna) in treatment of diabetes mellitus. This study provides scientific support to Ayurvedic claims that the Bhavana process has pharmaceutico-therapeutic significance in Ayurvedic drug development.

Zahiruddin et al., used the response surface methodology (RSM) to optimize the ratio of aqueous extracts of Phyllanthus emblica L., Piper nigrum L., Withania somnifera (L.) Dunal and T. cordifolia (Willd.) Miers for the development of a combination formulation. The developed polyherbal formulation showed significant immunomodulatory activity on cyclophosphamide-induced immunosuppressed mice. The metabolomic study showed more than 180 metabolites, identified through LC-MS in the optimized combination. Polyherbal combination treatment significantly (p < 0.01) enhanced the subsets of immune cells such as NK cells, B cells, CD4, and CD8 cells.

Berberis aristata DC. and Nigella sativa L. are plants traditionally used in AYUSH medicine. Mazhar et al., describe a method of standardization of B. aristata and N. sativa and investigated their anticancer activity in the 7, 12-dimethylbenz[a]anthracene (DMBA)-induced mouse model. Molecular docking was carried for marker compounds of both the plants with metabolomic studies of essential oils using GC-MS. The study showed that the extracts of N. sativa and B. aristata, as well as their marker compounds, showed an antitumor activity and had no harmful effects on female mice. Furthermore, they protected against DMBA-induced tumor in a mouse model.

Sigesbeckia orientalis L. (syn.: Siegesbeckia orientalis L.)' (SO) is a remedy in traditional Chinese medicine (TCM) used to reduce the symptoms of joint disorders. It is a toxic herb but it is hypothesized that by processing, according to TCM theory, its toxicity can be lowered. Jiang and co-authors, demonstrated using metabolomics that the raw SO causes pulmonary toxicity and by processing with rice wine its toxicity is reduced. This supports the classical SO processing theory with scientific evidence.

Anadenanthera colubrina (Vell.) Brenan, a plant with antifungal and anti-inflammatory properties, as studied by Maia et al., for its antifungal activity against Candida albicans, C. glabrata, C. tropicalis and C. dubliniensis using the broth microdilution method. Antifungal activity was assessed in terms of antibiofilm effects, proteolytic enzyme activities, by viability assays, gene expression and cytokines expressions. The extract showed significant antifungal activity against different Candida strains with low toxic effects to host cells.

Salunkhe et al., formulated two formulations of spray dried alcoholic extracts three different herbs namely Trigonella foenum-graecum L, Momordica charantia L, and Cinnamomum verum J. Presl. The oral bioavailability and pharmacokinetic profile of the formulations were evaluated in terms of their markers diosgenin, charantin, and hydroxychalcone in male wistar rats. The maximum oral bioavailability was found for charantin followed by diosgenin and then hydroxychalcone. A significant increase in bioavailability of all the markers were observed after addition of piperine.

Supercritical fluid extraction (SFE) is one of the extraction methods with advantages of short extraction time and high purity of extracts. Mishra et al., described the metabolite profiling of supercritical CO2 extracts of the Indian variety of Ophiocordyceps sinensis earlier known as Cordyceps sinensis (CS) using HPTLC and GCMS, followed by chemometric analysis. The extract was foud effective against Escherichia coli and Salmonella typhi by generation of reactive oxygen species and can be utilized in mycotherapeutics for multiple bioeffects.

Wang et al., explored the dose-effect/toxicity relationships between high and low dose of lower polar fraction of Bupleuri Radix (root of Bupleurum chinense DC.) and its mechanism using the liver metabolomics in chronic unpredictable mild stress (CUMS) rats. The median toxicity dose and effective safe dose of Bupleuri Radix were calculated which caused liver injury in high dose and psychiatric diseases at low dose.

Tene et al., investigated the cardioprotective effect of Dillenia pentagyna Roxb. (DP) against doxorubicin (Dox)-induced cardiotoxicity in vitro as well as in vivo. The finding suggested that the phenol rich extract/fractions of DP helped in alleviating the Dox-induced cardiotoxicity. LC-QTOF-ESI-MS analysis of bioactive extract/fractions indicated that polyphenols like gallic acid, syringic acid, and sinapic acid could be responsible for the potent cardioprotective effect due to their antioxidant properties.

Erukainure et al., investigated cardioprotective mechanisms of a traditional medicinal plant of South Africa, Turbina oblongata (E. Mey. ex Choisy) A. Meeuse. The results indicated that plant has potential to mitigate lipotoxicity and control dysregulated cardio-metabolic activities due to its antioxidant potential and suppressive effects on angiotensin converting enzyme, lipase and acetyl cholinesterase enzymes.

Mahuang decoction (MHD) is a well-known traditional Chinese medicine, on which Liao and his co-workers reported its protective effect against lipopolysaccharide and D-galactosamine (LPS/D-GalN)-induced acute liver failure (ALF) in a mouse model. MHD showed protective effect by regulating the tricarboxylic acid cycle and amino acid metabolism. UPLC-MS was undertaken done for metabolomic studies and revealed that in serum samples, 36 metabolites were identified as contributing to LPS/D-GalN-induced ALF, whereas 27 among them were ameliorated on administration of MHD.

Erukainure et al., worked on the tetrahydrocannabinol-rich extract of Cannabis sativa L. in the context of neurodegenerative disorders. The extract was found to improve glucose intake and to suppress oxidative stress and cholinergic dysfunction, as well as to modulate purinergic and gluconeogenic activity in brain tissues of rats. In silico analysis revealed that constituents of the extract can pass the blood brain barrier whereas GC-MS analysis confirmed the presence of tetrahydrocannabinol in the plant extract.

Safoof-e-Pathar phori (SPP) is a poly-herbomineral formulation, which has been used traditionally for urolithiasis as per the Unani Pharmacopoeia of India. Ahmad et al., investigated the traditional claim pre-clinically. The study involved the oral administration of SPP at low and high doses. They significantly (P < 0.001) reduced lower urinary calcium, serum creatinine, blood urea, and lipid peroxidation in urolithiatic wistar rats. The long-term oral toxicity study showed that the SPP was safe in Wistar rats for up to three months. The study provides scientific evidence in support of traditional claims for SPP as an antiurolithiatic formulation.

Luo et al., explored the high-throughput metabolomic analysis to identify the biomarkers and pathways to reveal the therapeutic action and mechanism of andrographolide against lung cancer using UPLC-TOF/MS. The findings suggest that 11 metabolism pathways are regulated by andrographolides in cancer. Network pharmacology revealed the involvement of 570 proteins. Amino acid metabolism and arachidonic acid metabolism pathways are the potential target pathways for andrographolide in this model of lung cancer.

Kumar et al., investigated the neuroprotective effect of piperine on streptozotocin-induced hyperglycemia and also observed the gene expression in diabetic rats. Piperine not only lead to significant improvement in memory but also to a significant reduction in the expression of specific Alzheimer's disease-related genes, like BACE1, PSEN1, APAF1, CASPASE3, and CATALASE.

Radix Bupleuri (RB) and Radix paeoniae Alba (RPA) is a well-known herb combination used clinically to treat depression. Chen et al., developed a novel and efficient technique for analyzing the impact of the combination of RB and RPA in in vivo behaviours by combining multi-component pharmacokinetics with metabolomics. The finding of the study suggested that the combination can increase the bioavailability of 6 components in RPA and 5 in RB and also boosts neuroprotective and anti-inflammatory effects.

Tiwari et al., used chromatographically standardized extracts of Clerodendrum serratum (L.) Moon (Verbenaceae) for assessing its anti-inflammatory and anti-arthritic activities. Thereby scientific evidence for the ethnomedicinal use of the plant in arthritis is provided.

Nandanwadkar et al., used the inductive coupled plasma-optical emission spectroscopy (ICP-OES) technique to carry out multi-elemental assessments of phyto-pigments. They also used using chromatographic technique to evaluate the biotherapeutic potential. The screening for heavy metals and micro and macro minerals were undertaken using routine quality control and safety profile of food additives and contaminants.

Lin et al., focused on two traditional Chinese medicine (Acanthopanax senticosus (Rupr. & Maxim.) Harms (ASE) and Gastrodia elata Blume (GEB) for the treatment of stroke and cerebrovascular diseases. Using transcriptomic and metabolomic studies together authors hypothesized that both drugs can be used for the treatment of cerebrovascular diseases. Six metabolites and six genes were found to be significantly altered. The therapeutic effect of extracts in cerebrovascular diseases was found to be related to the regulation of the phenylalanine and pyrimidine metabolic pathways.

Pseudevernia furfuracea (L.), is an epiphytic lichen, used in Indian spice mixtures, curries and food preparations as a preservative. Goel et al., attempted to find the optimal extraction method for polyphenol and flavonoid enriched extracts of P. furfuracea. Scanning electron microscopy and HPLC analysis were used to compare the effect of pre-processing conditions on extraction method. UHPLC-DAD-MS was used to study the metabolomic profile of the lichen extracts. A 70% methanol extract after mixing and grinding the raw material by using soxhlet was found to be the most effective for extracting a combination of polyphenolic and flavonoidal rich metabolites. The work also suggested P. furfuracea as a potent antioxidant.

Sing et al., suggested a system for grading Andrographis paniculata (Burm. F) raw ground samples using NIR (near infrared reflectance) spectroscopy and SVM (support vector machine) classifier based on the content of the marker, andrographolide. Estimation accuracy based on extracts was marginally higher than that based on powder leaf samples. However, it had no effect on the samples' grading pattern. The finding of the study suggested that by combining NIR-based estimate of powdered leaf samples with an SVM classifier can be a low-cost solution for grading the samples rapidly.

Mou et al., summarized the structural types, pharmacological activities, and mechanisms of Dendrobium alkaloids, as well as the suggested biogenetic pathways of dendrobine, which is an important sesquiterpene alkaloid.

Tawfeek et al., provided a comprehensive overview of the phytochemistry, traditional use, and pharmacology of plant extracts and constituents from the genus Salix (willows). They also demonstrated its ability to reduce inflammatory pathways, and hypothesized that could be useful in cancer prevention and therapy, as well as other chronic diseases.

Bhatt et al., explored Indian system of medicines for possible male and female contraceptives. The review concluded, Indian system of medicine offers highly promising opportunities with potential analytical, biological, technological, and clinical advances collectively integrated with therapeutic rationale based on Ayurvedic principles.

Nille et al. provided information on a traditional plant, Avartaki (Senna auriculata (L.) Roxb.) and its wide usefulness in Ayurveda and Siddha systems of medicine for the treatment of numerous diseases. The ethnomedicinal, phytochemical, pharmacological, and toxicological features of the plant were discussed in this review article, with more focus on therapeutic significance in diabetes.

Overall, this special issue provides an insight into the role of metabolomics and ethnopharmacology in the development of herbal and traditional medicine. It provides the readers with a plethora of generally up-to-date information to support their understanding of these rapidly evolving areas of metabolomics. Still, there are enormous scope to work on metabolomics and network pharmacology of traditional medicine for better understanding of molecular mechanism of pharmacological actions by identifying metabolites through dereplication and to provide data for scientific validation of traditional claims.

4,090 views

12 citations

ORIGINAL RESEARCH
22 September 2021
The Novel Chinese Medicine JY5 Formula Alleviates Hepatic Fibrosis by Inhibiting the Notch Signaling Pathway
Yadong Fu, 15 more and Ping Liu

7,498 views

30 citations

ORIGINAL RESEARCH
7 September 2021
Dose-Effect/Toxicity of Bupleuri Radix on Chronic Unpredictable Mild Stress and Normal Rats Based on Liver Metabolomics
Peng Wang, 6 more and Xuemei Qin

5,370 views

21 citations

Avartaki (Senna auriculata (L.) Roxb. syn. Cassia auriculata L.; Family- Fabaceae ) is a traditional medicinal plant, widely used for the treatment of various ailments in Ayurveda and Siddha system of medicine in India. Almost all the parts of the plant, such as flowers, leaves, seeds, barks, and roots have been reported for their medicinal uses. Traditionally, it has been used in the treatment of diabetes, asthma, rheumatism, dysentery, skin disease, and metabolic disorders. The principle phytochemicals in Senna auriculata (L.) Roxb. are alkaloids, anthraquinone, flavone glycosides, sugar, saponins, phenols, terpenoids, flavonoids, tannins, steroids, palmitic acid, linoleic acid, benzoic acid 2-hydroxyl methyl ester, 1-methyl butyl ester, resorcinol, α-tocopherol-β-D-mannosidase, epicatechin, ferulic acid, quercetin-3-O-rutinoside, quercetin, proanthocyanidin B1. The extracts from its different parts and their isolated compounds possess a wide range of pharmacological activities such as antidiabetic, antioxidant, anti-inflammatory, antihyperlipidemic, hepatoprotective, nephroprotective, cardioprotective, anti-atherosclerotic, anticancer, antimutagenic, antimicrobial, antiulcer, antipyretic, anthelmintic, immunomodulatory, antifertility, anti-venom, and anti-melanogenesis. The toxicological findings from preclinical studies ensured the safety of the plant, but comprehensive clinical studies are required for the safety and efficacy of the plant in humans. The current review article aimed to provide up-to-date information about Senna auriculata (L.) Roxb. covering its ethnomedicinal, phytochemical, pharmacological, and toxicological aspects with special emphasis on its clinical implications in diabetes.

33,547 views

47 citations

ORIGINAL RESEARCH
26 August 2021
Supercritical Carbon Dioxide Extracts of Cordyceps sinensis: Chromatography-based Metabolite Profiling and Protective Efficacy Against Hypobaric Hypoxia
Jigni Mishra, 2 more and Kshipra Misra

8,353 views

12 citations

The Effects of Erchen Decoction on Gut Microbiota and Lipid Metabolism Disorders in Zucker Diabetic Fatty Rats
ORIGINAL RESEARCH
22 July 2021
The Effects of Erchen Decoction on Gut Microbiota and Lipid Metabolism Disorders in Zucker Diabetic Fatty Rats
Tian Zhao, 7 more and Shenlin Liu
Obesity is a chronic metabolic disease caused by genetic and environmental factors that has become a serious global health problem. There is evidence that gut microbiota is closely related to the occurrence and development of obesity. Erchen Decoction (ECD), a traditional Chinese medicine, has been widely used for clinical treatment and basic research of obesity and related metabolic diseases in recent years. It can significantly improve insulin resistance (IR) and lipid metabolism disorders. However, there is no microbiological study on its metabolic regulation. In this study, we investigated the effects of ECD on obesity, especially lipid metabolism and the composition and function of gut microbiota in Zucker diabetic fatty (ZDF) rats, and explored the correlation between the biomarkers of gut microbiota and metabolite and host phenotype. The results showed that ECD could reduce body weight, improve IR and lipid metabolism, and reduce the concentration of free fatty acids (FFA) released from white adipose tissue (WAT) due to excessive lipolysis by interfering with the insulin receptor substrate 1 (IRS1)/protein kinase B (AKT)/protein kinase A (PKA)/hormone-sensitive triglyceride lipase (HSL) signaling pathway in ZDF rats. Additionally, ECD gradually adjusted the overall structure of changed gut microbiota, reversed the relative abundance of 6 genera, and changed the function of gut microbiota by reducing the content of propionic acid, a metabolite of gut microbiota, in ZDF rats. A potentially close relationship between biomarkers, especially Prevotella, Blautia, and Holdemania, propionic acid and host phenotypes were demonstrated through correlation analysis. The results suggested that the beneficial effects of ECD on obesity, especially lipid metabolism disorders, are related to the regulation of gut microbiota in ZDF rats. This provides a basis for further research on the mechanism and clinical application of ECD to improve obesity via gut microbiota.

8,658 views

63 citations

Variable Secondary Metabolite Profiles Across Cultivars of Curcuma longa L. and C. aromatica Salisb.
ORIGINAL RESEARCH
30 June 2021
Variable Secondary Metabolite Profiles Across Cultivars of Curcuma longa L. and C. aromatica Salisb.
Poonam Kulyal, 4 more and Agepati S. Raghavendra
Abstract Background: Curcuma spp. (Zingiberaceae), are used as a spice and coloring agent. Their rhizomes and essential oils are known for medicinal properties, besides their use in the flavoring and cosmetic industry. Most of these biological activities were attributed to volatile and non-volatile secondary metabolites present in the rhizomes of Curcuma spp. The metabolite variations among the species and even cultivars need to be established for optimized use of Curcuma spp. Objectives: We compared the phytochemical profiles of rhizomes and their essential oils to establish the variability among seven cultivars: five of Curcuma longa L. (Alleppey Supreme, Duggirala Red, Prathibha, Salem, Suguna), and two of C. aromatica Salisb. (Kasturi Araku, Kasturi Avidi). The GC-MS and LC-MS-based analyses were employed to profile secondary metabolites of these selected cultivars. Methods: Rhizomes of Curcuma spp. were subjected to hydro-distillation to collect essential oil and analyzed by GC-MS. The methanol extracts of fresh rhizomes were subjected to LC-MS analyses. The compounds were identified by using the relevant MS library databases as many compounds as possible. Results: The essential oil content of the cultivars was in the range of 0.74% to 1.62%. Several compounds were detected from the essential oils and rhizome extracts by GC-MS and LC-MS, respectively. Of these, 28 compounds (13 from GCMS and 15 from LCMS) were common in all seven cultivars, e.g. α-Thujene, and diarylheptanoids like Curcumin. Further, a total of 39 new compounds were identified from C. longa L. and/or C. aromatica Salisb., most of them being cultivar-specific. Of these compounds, 35 were detected by GC-MS analyses of essential oils: 1,2-Cyclohexanediol, 1-methyl-4-(1-methylethyl)-; santolina alcohol; to name a few. The other four compounds were detected by LC-MS of the methanolic extracts of the rhizomes, e.g., kaempferol-3,7-O-dimethyl ether and 5,7,8-trihydroxy-2′,5′-dimethoxy-3′,4′-methylene dioxyisoflavanone. Conclusions: We identified and recorded the variability in the metabolite profiles of essential oils and whole rhizome extracts from seven cultivars of Curcuma longa L. and C. aromatica Salisb. As many as 39 new metabolites were detected in these seven Indian cultivars of Curcuma spp. Many of these compounds have health benefits.

9,529 views

38 citations

ORIGINAL RESEARCH
14 June 2021
Dendrobium Officinale Polysaccharide Attenuates Insulin Resistance and Abnormal Lipid Metabolism in Obese Mice
Jian Qu, 9 more and Qiong Lu
Dendrobium Officinale Polysaccharide Attenuates Insulin Resistance and Abnormal Lipid Metabolism in Obese Mice
Objectives: Dendrobium officinale polysaccharide (DOP) is the main active ingredient in a valuable traditional Chinese medicine, which exerts several pharmacological activities including hepatoprotection and hypoglycemic effects. However, the effects of DOP on obesity-associated insulin resistance (IR) and lipid metabolism remain unknown. This study aimed to investigate the role of DOP in IR and abnormal lipid metabolism in obese mice. Methods: IR models were established using 3T3-L1 adipocytes, C2C12 myocytes, and primary cultured hepatocytes exposed to palmitate acid. After treatment with DOP, insulin-stimulated glucose uptake, glucose release, and AKT phosphorylation was detected. Fasting blood glucose, fasting serum insulin, the glucose tolerance test (GTT), and the insulin tolerance test (ITT) were measured to evaluate IR of obese mice. Lipid analysis was conducted to evaluate the effects of DOP on lipid metabolism in obese mice. Results: In vitro, DOP treatment ameliorated palmitic acid-induced IR in adipocytes, myocytes, and hepatocytes. DOP regulated cellular insulin sensitivity via the peroxisome proliferator-activated receptor-γ (PPAR-γ). Furthermore, administration of DOP significantly reduced the IR and visceral adipose tissue (VAT) inflammation of diet-induced obese (DIO) and the genetically-induced obesity mice (ob/ob) mouse models. In addition, DOP treatment attenuated the high-fat diet (HFD)-induced liver lipid accumulation by reducing liver triglycerides (TG), plasma free fatty acid (FFA), serum cholesterol (TC), and low-density lipoprotein cholesterol (LDL-C) levels, while increasing HDL-C levels. Conclusions: DOP could improve obesity-associated IR and abnormal lipid metabolism through its activities on PPAR-γ, and may serve as a potential therapeutic agent for obesity-associated insulin resistance and lipid metabolism disorder.

7,194 views

53 citations

ORIGINAL RESEARCH
17 May 2021
Polyphenolic-Rich Compounds From Dillenia pentagyna (Roxb.) Attenuates the Doxorubicin-Induced Cardiotoxicity: A High-Frequency Ultrasonography Assisted Approach
Kalyani Tene, 8 more and V. G. M. Naidu

8,837 views

25 citations

In-Vitro α-amylase, α-glucosidase Inhibitory Activities and In-Vivo Anti-Hyperglycemic Potential of Different Dosage Forms of Guduchi (Tinospora Cordifolia [Willd.] Miers) Prepared With Ayurvedic Bhavana Process
Guduchi (Tinospora cordifolia [Willd.] Miers) is a flagship rejuvenating herb of Ayurveda with reported anti-diabetic potential. In the present study, different dosage forms of Guduchi stem (growing on neem tree) were developed by adopting Ayurvedic pharmaceutical process of Bhavana (levigation). Guduchi Churna (GC) was subjected to 07 times Bhavana separately with its own extracted juice, decoction and potable water, and dosage forms namely Svarasa Bhavita Guduchi Churna (SBGC), Kwatha Bhavita Guduchi Churna (KBGC), and Jala Bhavita Guduchi Churna (JBGC) were prepared. The present study was aimed to evaluate the role of Bhavana on the potentiation of therapeutic properties of Guduchi. Sequential solvent extracts (5%, 10%, 15% and 25%) of GC, SBGC, KBGC and JBGC were prepared in different solvents [phosphate buffer, hexane, dichloromethane (DCM), chloroform] and screened for the α-amylase and α-glucosidase inhibitory activity. The results revealed that phosphate buffer and DCM extracts of SBGC exhibited strong α-amylase inhibitory potential (>80% inhibition at 25% concentration) followed by KBGC, JBGC and GC with reference to the standard acarbose. In α-glucosidase inhibitory activity, maximum inhibition was observed in DCM and chloroform extracts of SBGC (>85% inhibition at 25% concentration), followed by KBGC (>80% inhibition at 25% concentration), JBGC and GC. In vivo anti-hyperglycemic studies were carried out by oral glucose tolerance test in Swiss albino mice. Test drugs (JBGC, KBGC, SBGC) treated groups showed marginal decrease of blood glucose levels in normo glycemic mice. However, the blood glucose level in test drug JBGC, KBGC and SBGC treated groups was still within normal range in overnight fasted mice. In oral glucose tolerance test, among all dosage forms SBGC (51.08%) produced a pronounced anti-hyperglycemic effect followed by KBGC (42.57%) at a dose of 520mg/kg. The GC, JBGC, KBGC and SBGC samples were also standardized using berberine (a well established anti-diabetic compound) as a marker compound by HPTLC fingerprint analysis. Findings of the present study indicate that SBGC and KBGC can be used in the treatment of diabetes mellitus and gives supporting evidence to Ayurvedic claims that the Bhavana process has pharmaceutico-therapeutic significance in Ayurvedic drug development.

10,095 views

58 citations

ORIGINAL RESEARCH
6 May 2021
Estimation of Andrographolides and Gradation of Andrographis paniculata Leaves Using Near Infrared Spectroscopy Together With Support Vector Machine
Dilip Sing, 7 more and Pulok K. Mukherjee

4,827 views

16 citations